Fig. 4

Enriched terms and pathways between respective two groups. Distinct top-20 GO terms in DRGs between Control vs CAIA (A), CAIA vs CAIA + Baricitinib (B), and CAIA + Celecoxib vs CAIA + Baricitinib (C), determined using by clusterProfiler. Heatmaps of significantly enriched Hallmark pathways in DRG between Control vs CAIA (D), CAIA vs CAIA + Baricitinib (E), and CAIA + Celecoxib vs CAIA + Baricitinib (F)